CD133 expression in human gliomas of different grades before and after chemotherapy and in the recurrent situation quantified by real-time RT-PCR

Moritz Perrech, Gabriele Röhn, Roland Goldbrunner & Marco Timmer
Objective: Cancer stem cells represent a population of tumorigenic cells responsible for tumor development and growth. CD133 antigen has been described as a potential stem cell marker in human glioma that might act as biomarker to identify such a tumorigenic population. Due to their high resistance [for full text, please go to the a.m. URL]